Inovio Pharmaceuticals saw the highest growth of 2.32% in patent filings in April and 1.79% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 2.32% and grants by 1.24%. GlobalData’s DataBook provides a comprehensive analysis of Inovio Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Inovio Pharmaceuticals has been focused on protecting inventions in Australia(AU) with 11 publications in Q2 2024
The Australia(AU) Patent Office dominates the patent filings and grants with nearly 25% filings and 22% grants. The Australia(AU), United States(US), China(CN), and European Patent Office(EPO) patent Office are among the top ten patent offices where Inovio Pharmaceuticals is filings its patents. Among the top granted patent authorities, Inovio Pharmaceuticals has 22% of its grants in Australia(AU), 22% in United States(US) and 11% in South Korea(KR).
GSK could be the strongest competitor for Inovio Pharmaceuticals
In terms of grant share, Inovio Pharmaceuticals stands in fifth position among its competitors. Inovio Pharmaceuticals and GSK secured the top positions according to recent patent publication data.
Patents related to rare diseases and climate change lead Inovio Pharmaceuticals's portfolio
Inovio Pharmaceuticals has the highest number of patents in rare diseases followed by, climate change and emissions reduction. For rare diseases, nearly 43% of patents were filed and no patents were granted in Q2 2024.
Automobile batteries related patents lead Inovio Pharmaceuticals portfolio followed by advanced batteries, and drug delivery devices
Inovio Pharmaceuticals has highest number of patents in automobile batteries followed by advanced batteries, drug delivery devices, human papillomavirus infections, and brain cancer. For automobile batteries, nearly 12% of patents were filed and 19% of patents were granted in Q2 2024.
For comprehensive analysis of Inovio Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
